Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-03-19

Clinical Trial Update: Immunogenicity of Hepatitis A Vaccine in Inflammatory Bowel Disease (IBD) Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated the immunogenicity of a Hepatitis A vaccine in patients with inflammatory bowel disease, including Crohn's disease and ulcera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hepatitis A vaccine (inactivated Hepatitis A vaccine)

Snippet

Sponsor: Asan Medical Center | Conditions: Inflammatory Bowel Disease, Crohn's Disease | Phase 4 | Status: COMPLETED